Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Mater Chem B ; 2(36): 6054-6063, 2014 Sep 28.
Article in English | MEDLINE | ID: mdl-32261857

ABSTRACT

Chitosan films containing mesoporous SBA-15 supported silver nanoparticles (AgNPs) were prepared to be applied as a potential wound dressing material. First SBA-15-silver nanoparticle (SBA-15-Ag) composite materials were prepared by a controlled annealing process without the use of organic solvents and reagents. The SBA-15-AgNPs were characterized in detail by X-ray powder diffraction, field emission scanning electron microscopy and transmission electron microscopy which evidenced the presence of uniformly distributed silver nanostructures inside the silicate pores. UV-vis spectra of the sample showed a band at 430 nm characteristic of the surface plasmon resonance of silver nanoparticles with a diameter below 10 nm and X-ray photoemission spectra confirmed the formation of metal-nanoparticles on the silicate template. Then SBA-15-Ag was used to prepare chitosan films which were characterized in detail. In particular, they showed good hydration properties, water vapor transmission rate and mechanical properties. After hydration films exhibited good antimicrobial activity against both Gram-negative (Pseudomonas aeruginosa) and Gram-positive (Staphylococcus epidermidis and S. aureus) bacteria.

2.
Tumori ; 94(6): 869-72, 2008.
Article in English | MEDLINE | ID: mdl-19267109

ABSTRACT

Granulocytic sarcomas (chloromas) are rare extra-medullary tumors arising from primitive granulocytic cells. The term "chloroma" is derived from the Greek word chloros (green), and it refers to the frequently greenish color of the tumor, which is due to the presence and oxidation of the myeloperoxidase enzyme. These tumors can arise de novo or can be associated with other myeloid disorders, such as acute or chronic myeloid leukemia, myeloproliferative or myelodysplastic conditions. Presentation can occur prior to, in association with the underlying myeloid disorder, or upon relapse. The location of the tumor can vary: sub-periosteal bone, skull, pelvis, ribs, sternum or lymph nodes. We report the case of a 58-year-old man who presented right exophthalmos and ophthalmoplegy with computerized tomography (CT) evidence of a retro-orbital mass, which histology confirmed to be a granulocytic sarcoma.


Subject(s)
Exophthalmos/pathology , Leukemia, Myeloid/complications , Orbital Neoplasms/pathology , Sarcoma, Myeloid/pathology , Exophthalmos/diagnostic imaging , Exophthalmos/surgery , Humans , Leukemia, Myeloid/pathology , Male , Middle Aged , Orbital Neoplasms/diagnostic imaging , Orbital Neoplasms/surgery , Sarcoma, Myeloid/diagnostic imaging , Sarcoma, Myeloid/surgery , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL